Ghiani Lavinia, Chiocca Susanna
Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milan, Italy.
Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milan, Italy.
Tumour Virus Res. 2024 Dec 5;19:200301. doi: 10.1016/j.tvr.2024.200301.
Understanding the role of NSD proteins in virus-induced cancers could reveal new therapeutic strategies. Targeting NSD proteins may not only disrupt the epigenetic changes triggered by viruses but also help restore normal cellular function. For instance, developing NSD inhibitors could counteract abnormal histone modifications caused by viral infections and slow cancer progression. Our review on the NSD protein family emphasizes its critical role in epigenetic regulation and cancer progression, also in virus-induced cancers. As research on the molecular mechanisms of NSD proteins advances, these proteins are emerging as promising candidates for targeted cancer therapies, particularly in cancers driven by histone modifications and transcriptional dysregulation.
了解NSD蛋白在病毒诱导的癌症中的作用可能会揭示新的治疗策略。靶向NSD蛋白不仅可以破坏病毒引发的表观遗传变化,还可能有助于恢复正常的细胞功能。例如,开发NSD抑制剂可以抵消病毒感染引起的异常组蛋白修饰,并减缓癌症进展。我们对NSD蛋白家族的综述强调了其在表观遗传调控和癌症进展中的关键作用,在病毒诱导的癌症中也是如此。随着对NSD蛋白分子机制研究的进展,这些蛋白正成为靶向癌症治疗的有希望的候选者,特别是在由组蛋白修饰和转录失调驱动的癌症中。